Volume 10, Number 1—January 2004
Domestically Acquired Campylobacter Infections in Finland
Highlight and copy the desired format.
|EID||Vierikko A, Hänninen M, Siitonen A, Ruutu P, Rautelin H. Domestically Acquired Campylobacter Infections in Finland. Emerg Infect Dis. 2004;10(1):127-130. https://dx.doi.org/10.3201/eid1001.020636|
|AMA||Vierikko A, Hänninen M, Siitonen A, et al. Domestically Acquired Campylobacter Infections in Finland. Emerging Infectious Diseases. 2004;10(1):127-130. doi:10.3201/eid1001.020636.|
|APA||Vierikko, A., Hänninen, M., Siitonen, A., Ruutu, P., & Rautelin, H. (2004). Domestically Acquired Campylobacter Infections in Finland. Emerging Infectious Diseases, 10(1), 127-130. https://dx.doi.org/10.3201/eid1001.020636.|
Campylobacter jejuni isolates (n = 533) from domestic cases diagnosed in Finland during a 3-month peak period were studied. The highest rate was observed among those 70–74 years of age. Domestic C. jejuni isolates were especially frequent in the eastern districts. Six serotypes covered 61% of all C. jejuni isolates.
In developed countries, campylobacters are the most common culture-confirmed bacterial causes of gastroenteritis (1,2). The most common species identified in patients is Campylobacter jejuni. Since 1998, campylobacters also have been the most common bacterial enteropathogens detected in Finnish patients. A similar increasing trend has been recognized in many other European countries, such as Sweden, Denmark, and the United Kingdom (3–5). The epidemiology and modes of transmission are not well known, but risk factors for acquiring Campylobacter infection include handling or eating chicken, barbecuing, drinking unpasteurized milk or contaminated water, and traveling abroad (1,6–8).
Some 30%-40% of Campylobacter infections detected in Swedish persons have been acquired in Sweden (3). Yet, in Denmark, approximately 80% of human infections are of domestic origin (4), suggesting that differences in risk factors may exist in these neighboring countries. In Finland, since 1994, all clinical microbiology laboratories are required to notify the National Infectious Disease Register (NIDR) of all Campylobacter findings based on culture, but no data on the distribution of domestically acquired and imported Campylobacter infections are collected.
We attempted to collect all Campylobacter isolates cultured in Finland from clinical stool samples of patients with domestically acquired infections during the seasonal peak of Campylobacter infections in 1999 and to analyze the heat-stable serotypes of C. jejuni strains.
All clinical microbiology laboratories culturing campylobacters in Finland were asked to collect domestic Campylobacter isolates detected from human clinical fecal samples. Isolates collected on July 1 through September 30, 1999, from patients who had not been abroad for 2 weeks before becoming ill, were considered of domestic origin and were included in the study. Information on foreign travel, received by the physicians, was collected by the local clinical microbiology laboratories when culture results were reported to the clinical unit. The isolates were sent to Helsinki University Central Hospital (HUCH) Laboratory Diagnostics along with information about the patient (date of birth, sex, recent travel history) and the isolate (date of stool sampling, hippurate hydrolysis result). Consecutive isolates from the same patient were excluded. Isolates were stored at –70°C before serotyping. Hippurate-positive (C. jejuni) isolates were subsequently serotyped based on heat-stable Penner’s (Pen) antigens by passive hemagglutination using a serotyping set including 25 antisera (Campylobacter Antisera Seiken Set, Denka Seiken Co., Tokyo) as earlier described (9).
A total of 3,303 Campylobacter cases in Finland in 1999 were reported to NIDR; of these, 1,412 (43%) cases were diagnosed during our study period. In the present study, a total of 551 Campylobacter isolates were collected from patients who had presumably acquired their infections in Finland. The absence of case linkage between the two data sources prevents exact correlation between them; however, the number of domestic cases from the isolate collection is approximately 40% of the number of cases in NIDR for the same period. Of the strains collected, 533 (97%) were C. jejuni and 18 (3%) were C. coli. (Consecutive isolates related to outbreaks were not detected.)
The 533 case-samples of domestic C. jejuni infection collected within a population of 5.17 million yields a rate of 41.2 domestic C. jejuni cases per 100,000 inhabitants for the 3-month period. A higher proportion of patients were male (304 males, 57%). The rate of domestic C. jejuni infections by age group varied from 19.6 to 72.8 per 100,000 inhabitants for the 3-month period, with the highest rates observed among those >60 years old, among young adults (20–34 years of age), and among children <5 years of age (Figure 1).
Based on the municipality of the clinical unit from which the stool culture had been sent, several eastern hospital districts had high rates of domestic Campylobacter cases during the study period; the 95 % confidence intervals for these cases did not overlap those in several southern and western hospital districts with low rates (Figure 2). In some eastern districts, domestically acquired Campylobacter infections comprised even more than 80% of all cases reported to NIDR in July. In the other hospital districts, a peak was also demonstrated in July; then the number of domestic C. jejuni cases declined in August, and the number of isolates collected in September comprised only 10% of all strains isolated during the 3-month study period.
The seasonal distribution of the different serotypes is presented in the Table. The predominant serotypes (Pen 1,44, Pen 2, Pen 4-cluster, Pen 6,7, Pen 12, and Pen 27) comprised 61% of the isolates (Table). No clear geographic differences in the distribution of serotypes were found. None of the strains reacted with the antisera against serotypes Pen 10, 32, 38, or 45. Reactions with serotype Pen 3 and Pen 8 antisera were only present in complex serotypes. Serotypes Pen 5, 11, 18, 19, 31, 52, and 55 (not included in the Table) were so uncommon that they together represented approximately 5% of all the isolates.
The mean age of all case-patients was 41.4 years. Patients infected with C. jejuni serotype Pen 15 (mean age 23.5 years, 95% CI 6.0, 41.0) or serotype Pen 2 (mean age 32.7 years, 95% CI 26.3, 39.0) were significantly younger than those infected with serotype Pen 27 (mean age 49.6 years, 95% CI 42.7, 56.4) or serotype Pen 6,7 (mean age 46.8 years, 95% CI 42.2, 51.4). The age distribution of serotypes Pen 2 and Pen 27 is shown in Figure 3. Differences between the age distributions of case-patients infected with other serotypes were not significant.
All hospital districts in Finland participated in this study, and the rate of domestically acquired C. jejuni infections, as measured by the number of isolates sent, was highest in several eastern hospital districts. The higher rates cannot be explained by urban versus rural lifestyle alone since the western districts in the study included rural and urbanized areas in an approximately similar proportion as in the eastern districts.
The six most commonly found serotypes accounted for approximately 60% of the cases. We have studied human domestic Campylobacter infections in Finland since 1995 (9–11) and found the same serotypes to be common among C. jejuni isolates collected during July through September, although annual variation in the relative proportion of predominant serotypes is evident. Serotypes Pen 1,44, Pen 2, and Pen 4-cluster have been found relatively often in human fecal samples in Denmark (4,12), England (13), and New Zealand (14), but serotypes Pen 6,7, Pen 12, and Pen 27 have been less common (<3% each) in those studies.
From May to September 1999, a total of 1,132 chicken flocks, representing most of the chicken meat produced and consumed in Finland, were monitored for campylobacters. Thirty-one C. jejuni–positive flocks were detected; the most common Penner serotypes identified were Pen 6,7 and Pen 12, found mainly from July through August (15). These particular serotypes were also commonly found in human infections in the present study in July and in August. Serotypes Pen 27 and Pen 4-cluster were also found in the chickens (15). These results indicate some overlapping between human and chicken strains at the serotype level. Humans and chicken may share a common source for C. jejuni, or humans may acquire the infection from contaminated chicken meat.
The highest rate of domestic C. jejuni infection was found among patients in the age group of 70–74 years, accompanied by an above average rate among patients 65–69 years old. This is the first report of such an age peak for C. jejuni (1,3,4). Furthermore, the age distribution of patients infected with isolates of certain serotypes suggests that older people in Finland may have somewhat different sources of infection than younger people. Serotypes Pen 6,7 and Pen 27, in particular, appeared to be relatively common among the elderly patients. In our study, serotype Pen 2 was more common than Pen 27 in all age groups <50 years of age (excluding the age group 25–29 years) but less common in all older groups. Since serotypes Pen 6,7 and Pen 27 are also common in chicken (15), there may be a link between raw poultry handling or chicken consumption practices and C. jejuni in the elderly.
During the 1999 seasonal peak, domestically acquired cases of C. jejuni in Finland were caused by the same serotypes that are most commonly found in other developed countries, yet some common serotypes in our study seem to be less common elsewhere. High rates were observed among elderly men and in the east of Finland. The six most common serotypes covered 61% of all isolates. We recommend further study to determine if the results were specific to the time period or representative of a persistent phenomenon.
Mr. Vierikko is a medical student doing research at Haartman Institute, University of Helsinki. His research interest is focused on Campylobacter infections.
We are grateful to the clinical microbiology laboratories that collected and sent isolates to us and to Pekka Holmström for statistical support.
This study was supported by the Helsinki University’s Research Funds and the National Public Health Institute, Helsinki, Finland. This study was presented in part at the 11th International Workshop on Campylobacter, Helicobacter, and Related Organisms in Freiburg, Germany, Sept. 1–5, 2001 (Abstract E-02).
- Friedman J, Neimann J, Wegener HC, Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nachamkin I, Blaser MJ, editors. Campylobacter, 2nd ed. Washington: American Society for Microbiology; 2000. p.121–38.
- Rautelin H, Hänninen M-L. Campylobacters: the most common bacterial enteropathogens in the Nordic countries. Ann Med. 2000;32:440–5.
- Swedish Institute for Infectious Disease Control. Communicable diseases in Sweden 2002. Report of the Department of Epidemiology. 2003. Available from: http://www.smittskyddsinstitutet.se
- Annual report on zoonoses in Denmark 2002. Ministry of Food, Agriculture and Fisheries. 2003. Available from: http://www.vetinst.dk
- Wheeler JG, Sethi D, Cowden JM, Wall PG, Rodrigues LC, Tompkins DS, Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. BMJ. 1999;318:1046–50.
- Kapperud G, Skjerve E, Bean NH, Ostroff SM, Lassen J. Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway. J Clin Microbiol. 1992;30:3117–21.
- Studahl A, Andersson Y. Risk factors for indigenous campylobacter infection: a Swedish case-control study. Epidemiol Infect. 2000;125:269–75.
- Rodrigues LC, Cowden JM, Wheeler JG, Sethi D, Wall PG, Cumberland P, The study of infectious disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection. Epidemiol Infect. 2001;127:185–93.
- Rautelin H, Hänninen M-L. Comparison of a commercial test for serotyping heat-stable antigens of Campylobacter jejuni with pulsed-field gel electrophoresis. J Med Microbiol. 1999;48:617–21.
- Hänninen M-L, Pajarre S, Klossner M-L, Rautelin H. Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol. 1998;36:1787–9.
- Hänninen M-L, Perko-Mäkelä P, Pitkälä A, Rautelin H. A three-year study of Campylobacter jejuni genotypes in humans with domestically acquired infections and in chicken samples from the Helsinki area. J Clin Microbiol. 2000;38:1998–2000.
- Moller Nielsen E, Engberg J, Madsen M. Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine. FEMS Immunol Med Microbiol. 1997;19:47–56.
- Fricker CR, Park RWA. A two-year study of the distribution of ‘thermophilic’ campylobacters in human, environmental and food samples from the Reading area with particular reference to toxin production and heat-stable serotype. J Appl Bacteriol. 1989;66:477–90.
- Hudson JA, Nicol C, Wright J, Whyte R, Hasell SK. Seasonal variation of Campylobacter types from human cases, veterinary cases, raw chicken, milk and water. J Appl Microbiol. 1999;87:115–24.
- Perko-Mäkelä P, Hakkinen M, Honkanen-Buzalski T, Hänninen M-L. Prevalence of campylobacters in chicken flocks during the summer of 1999 in Finland. Epidemiol Infect. 2002;129:187–92.
- Figure 1. Domestically acquired Campylobacter jejuni infections in Finland by age and sex, July–September 1999.
- Figure 2. Rate of domestically acquired Campylobacter jejuni infections in Finland per 100,000 inhabitants, July–September 1999.
- Figure 3. Pen 2 and Pen 27 serotypes among domestically acquired Campylobacter jejuni infections in Finland by age, July–September 1999.
- Table. Penner serotypes of Campylobacter jejuni isolates detected from human fecal samples of patients in Finland with domestically acquired infections, July–September 1999
Please use the form below to submit correspondence to the authors or contact them at the following address:
Hilpi Rautelin, Department of Bacteriology and Immunology, Haartman Institute, P.O. Box 12, FIN-00014 University of Helsinki, Helsinki, Finland; fax +358 9 1912 6382
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 21, 2010
- Page last updated: December 21, 2010
- Page last reviewed: December 21, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)